Literature DB >> 1797267

Gamma interferon production by lymphocytes from children infected with L. chagasi.

O Bacellar1, M Barral-Netto, R Badaró, E M Carvalho.   

Abstract

The present study was performed to evaluate the ability of lymphocytes from 18 children living in an endemic area of visceral leishmaniasis (VL) to produce gamma-interferon. These children had no previous history of VL and were considered to be infected with Leishmania chagasi based on leishmanial seroconversion. The gamma IFN levels were determined by radioimmunoassay on supernatants of lymphocyte cultures (3 x 10(6)/ml) stimulated with PHA (final dilution 1:10) and Leishmania chagasi antigen (10 micrograms/ml). The gamma-IFN production by lymphocytes from seroconverting children stimulated with PHA (178 +/- 151 U/ml) and Leishmania chagasi (47 +/- 77 U/ml) was significantly higher than that observed in visceral leishmaniasis. For clinical follow-up, these 18 seroconverting children were divided into three groups: asymptomatic infection (N = 4); self-healing subclinical illness (N = 9), and subclinical infection progressing to VL (N = 5). Gamma IFN levels in children with either asymptomatic or subclinical infection (65 +/- 85 U/ml) were significantly higher (P less than 0.003) than those observed in children progressing to VL (9 +/- 6 U/ml). The data demonstrate that there is an association between gamma IFN levels and the clinical course of Leishmania infection.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1797267

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  8 in total

1.  Further evidences on a new diagnostic approach for monitoring human Leishmania (L.) infantum chagasi infection in Amazonian Brazil.

Authors:  Fernando Tobias Silveira; Ralph Lainson; Adelson Alcimar Almeida De Souza; Marliane Batista Campos; Liliane Almeida Carneiro; Luciana Vieira Rego Lima; Patrícia Karla Santos Ramos; Cláudia Maria de Castro Gomes; Marcia Dalastra Laurenti; Carlos Eduardo Pereira Corbett
Journal:  Parasitol Res       Date:  2009-11-28       Impact factor: 2.289

2.  New challenges in the epidemiology and treatment of visceral leishmaniasis in periurban areas.

Authors:  Kathryn M Dupnik; Eliana L Nascimento; Joao F Rodrigues-Neto; Tatjana Keesen; Maria Zélia Fernandes; Iraci Duarte; Selma M B Jeronimo
Journal:  Drug Dev Res       Date:  2011-09       Impact factor: 4.360

3.  Recombinant cysteine proteinase from Leishmania (Leishmania) chagasi implicated in human and dog T-cell responses.

Authors:  Paulo Henrique da Costa Pinheiro; Suzana de Souza Dias; Kelsen Dantas Eulálio; Ivete L Mendonça; Simone Katz; Clara Lúcia Barbiéri
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

4.  Reactive oxygen intermediates, nitrite and IFN-gamma in Indian visceral leishmaniasis.

Authors:  R Kumar; K Pai; S Sundar
Journal:  Clin Exp Immunol       Date:  2001-05       Impact factor: 4.330

5.  Neutrophils contribute to development of a protective immune response during onset of infection with Leishmania donovani.

Authors:  Emma McFarlane; Cynthia Perez; Mélanie Charmoy; Cindy Allenbach; K Christine Carter; James Alexander; Fabienne Tacchini-Cottier
Journal:  Infect Immun       Date:  2007-12-03       Impact factor: 3.441

6.  Anti-parasite therapy drives changes in human visceral leishmaniasis-associated inflammatory balance.

Authors:  Théo Araújo-Santos; Bruno B Andrade; Leonardo Gil-Santana; Nívea F Luz; Priscila L Dos Santos; Fabrícia A de Oliveira; Meirielly Lima Almeida; Roseane Nunes de Santana Campos; Patrícia T Bozza; Roque P Almeida; Valeria M Borges
Journal:  Sci Rep       Date:  2017-06-28       Impact factor: 4.379

7.  Elevated TGF-beta levels in drug-resistant visceral leishmaniasis.

Authors:  Miskelyemen A Elmekki; Mogahid M Elhassan; Hani A Ozbak; Moawia M Mukhtar
Journal:  Ann Saudi Med       Date:  2016 Jan-Feb       Impact factor: 1.526

8.  The Schistosoma mansoni hepatic egg granuloma provides a favorable microenvironment for sustained growth of Leishmania donovani.

Authors:  Mohammed F Hassan; Yaobi Zhang; Christian R Engwerda; Paul M Kaye; Hannah Sharp; Quentin D Bickle
Journal:  Am J Pathol       Date:  2006-09       Impact factor: 4.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.